Patent · US Active

Agonist antibodies to IL-23 receptor

US7893215B2 · kind B2 · utility

15Cited by

3References

8Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Edward Bowman · Redwood City, US
Shi-Juan Chen · Yokohama, JP
Daniel J. Cua · Ramona, US
Kevin W. Moore · Palo Alto, US
Tatyana Churakova · Sunnyvale, US
Hong-Nhung Y. Nguyen · Santa Clara, US
Jason R. Chan · Palo Alto, US

Key dates

Filing date	Jul 22, 2009
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Jul 22, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.